Viking Holdings Ltd (the "Company" or "Viking") (NYSE: VIK) today reported financial results for the third quarter ended ...

Viking Therapeutics is a clinical-stage biopharmaceutical company that specializes in developing novel therapies for metabolic and endocrine disorders. Here's what investors should know.

Viking beat Wall Street's third quarter profit expectation by a penny per share, at $1.20 adjusted EPS, while also delivering ...

The company saw revenue growth of 19% in Q3 and generated about $2B, which was ahead of the consensus estimate by $10M, driven by increased capacity passenger cruise days and higher occupancy, among ...

PEMBROKE, Bermuda (AP) — PEMBROKE, Bermuda (AP) — Viking Holdings Ltd. (VIK) on Wednesday reported third-quarter net income of $514.1 million. On a per-share basis, the Pembroke, Bermuda-based company ...

Wondering what you need to host an amazing dinner this year? Explore our curated list of the best entertaining essentials.

NEW YORK, Nov. 19, 2025 /PRNewswire/ -- The COOL Company today announced it ranked 463 on the Deloitte Technology Fast 500 ™, ...

The Dow reversed higher, gaining 0.1% after the 30-component index sought firm direction during the session. Blue chips broke ...

At The Harbor at Opelika, the health and safety of our residents and team members is our highest priority. As part of our commitment to providing a clean, healthy and supportive environment, we have ...

Viking Therapeutics has captured market attention with a notable performance shift in recent weeks. The biotech firm's shares advanced more than 11% during t ...

A guide to the Carolina Renaissance Festival from the perspective of a frequent flier, learn the ins and outs of the event ...